WHAT THE RU­MA MAR­KER SYS­TEM IS OF­FE­RING:

URI­NE TES­TING WIT­HOUT SU­PER­VI­SI­ON, ANA­LY­SIS RAN­GE OF UP TO 100 SUB­S­TAN­CES

Pro­blem: Su­per­vi­sed uri­ne tests in the con­text of drug treat­ment are ne­ver ea­sy. The­re may be gen­der con­flicts, em­barras­sing mo­ments du­ring in­spec­tion, mis­trust due to as­su­med at­tempts at ma­ni­pu­la­ti­on.

 

Then the­re is the me­di­cal ethos and the con­cern of be­ing un­a­ble to ob­ser­ve as clo­se­ly as is ne­cess­a­ry. At the sa­me time, the­re is the wish of mee­ting pa­ti­ents wit­hout bi­as and ob­jec­tive­ly, to sup­port treat­ment pro­fes­sio­nal­ly and in the pa­ti­ent’s best in­te­rest. It’s not a simp­le task.

 

THE RU­MA MAR­KER-SYS­TEM SOL­VES THE­SE IS­SU­ES.
Wartezimmer vor der Urinkontrolle
How the sys­tem works: The Ru­ma mar­ker ser­ves as a “fin­ger­print” in the uri­ne sam­ple.

 

The in­di­vi­du­al mar­kers – PEGs with dif­fe­rent chain lengths – are not pro­ces­sed in the bo­dy. They are ex­creted com­ple­te­ly just as they we­re in­ge­sted. Sin­ce the sub­s­tan­ces do not have any ef­fects at all, they are neit­her me­di­cinal pro­ducts nor me­di­cal de­vices and, in fact, do not even need to be de­cla­red as an in­gre­di­ent, as has be­en con­fir­med by in­ter­na­tio­nal re­views, e.g., at EMA or FDA.

 

The dif­fe­rent chain lengths of our mar­kers ser­ve as a code. Eve­ry mar­ker is in­di­vi­dual­ly coded and uni­que. The mar­ker struc­tu­re is not chan­ged by ad­ding or ta­king any other sub­s­tan­ces. Seve­r­al cli­ni­cal stu­dies have left no doubt that de­tec­tion and iden­ti­fi­ca­ti­on of the in­di­vi­du­al mar­kers will not be im­pai­red by food or drink of many dif­fe­rent kinds, nor by ad­di­ti­on of any che­mi­cals such as oxi­dants, acids, al­ka­lis, etc. Qui­te the op­po­si­te.

 

Ma­ni­pu­la­ti­on at­tempts will be se­cu­re­ly re­cognis­ed and com­mu­ni­ca­ted in the scope of the Ru­ma mar­ker sys­tem.

Ana­ly­tics cer­ti­fied to ISO 17025.
The ana­ly­sis ran­ge com­pri­ses in­di­vi­du­al sub­s­tan­ces of the fol­lo­wing sub­s­tan­ce groups:

Opiates: e.g., dif­fe­ren­tia­ti­on bet­ween he­ro­in, street he­ro­in, mor­phi­ne, co­de­i­ne, di­hy­dro­co­de­i­ne…


Opi­oid an­al­ge­sics: e.g., Fen­ta­nyl, Tra­ma­dol, Ti­li­di­ne, Oxy­c­odo­ne, Bu­pren­or­phi­ne, Me­tha­do­ne and me­ta­boli­tes…


Ben­zo­dia­ze­pi­nes (in­cl. dif­fe­ren­tia­ti­on): e.g., Dia­ze­pam, Clo­na­ze­pam, Al­pra­zo­lam, Oxa­ze­pam, Lo­ra­ze­pam, Flu­ni­tra­ze­pam …

 

Co­cai­ne/me­ta­bolite

 

Am­phet­ami­nes: e.g., am­phet­ami­ne, me­t­ham­phet­ami­ne, Ec­sta­sy…


Can­na­bis


An­ti­de­pres­sants: e.g., Ci­tal­o­pram, Do­xe­pin, Amit­ri­pty­line, Imi­pra­mi­ne,

Tri­mi­pra­mi­ne, Fluo­xe­ti­ne…


LSD/PCP

 

Z-sub­s­tan­ces/psy­cho­tro­pic drugs

 

... and much mo­re

How does the Ru­ma mar­ker sys­tem work?

It’s simp­le – watch a brief vi­deo and be in­for­med.

Use of the Ru­ma® mar­ker sys­tem

Are you in­te­rested? 

 

Start the test pha­se for your prac­ti­ce free of char­ge and ea­si­ly right away.

The Ru­ma Mar­ker-Sys­tem has mul­ti­ple com­po­nents that we will pro­vi­de to you free of char­ge within the scope of the tri­al pha­se.

 

You can keep using the sys­tem af­ter the tri­al. We will gl­ad­ly al­so in­form you about costs within the scope of in­iti­al con­sul­ting. Sett­le­ment af­ter re­fer­ral or costs for self-pa­y­ers on re­quest.